<DOC>
	<DOC>NCT01113658</DOC>
	<brief_summary>The purpose of this study is to assess the efficacy of design improvements of the Spiracur SNaP Wound Care System. This study prospectively evaluates the safety and efficacy of current and new design iterations of components of the FDA-cleared Spiracur SNaP Wound Care System in order to optimize safety, efficacy, and system performance.</brief_summary>
	<brief_title>Clinical Evaluation of the SNaP Wound Care System</brief_title>
	<detailed_description />
	<mesh_term>Wounds and Injuries</mesh_term>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Pressure Ulcer</mesh_term>
	<mesh_term>Postphlebitic Syndrome</mesh_term>
	<mesh_term>Postthrombotic Syndrome</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>Wound &lt; 10 cm in greatest diameter Patient &gt;18 years of age Willing and able to sign informed consent Patients with woundrelated cellulitis Patients with thick eschar at wound base post debridement Patients with wounds located in an area not amenable to forming an air tight seal Ulcers due to inflammatory conditions such as pyodermagangrenosum, rheumatoid arthritis, vasculitis, cryoglobulinemia, necrobiosislipoidicadiabeticorum, lupus or pancreatic panniculitis, cryofibrinogenemia, calcinosis cutis, scleroderma, Raynaud's syndrome Patient has untreated osteomyelitis Patient is allergic to wound care products Patient wounds with exposed blood vessels not suitable for negative pressure therapy Pregnant or pregnancysuspected patients Subject actively participating in other clinical trials that conflict with the current study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>negative pressure wound therapy</keyword>
	<keyword>NPWT</keyword>
	<keyword>Spiracur</keyword>
	<keyword>SNaP Wound Care System</keyword>
</DOC>